ArticlePloS one2022

Preclinical evidence for mitochondrial DNA as a potential blood biomarker for chemotherapy-induced peripheral neuropathy.

Annalisa Trecarichi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.